IW
DXCM icon

Imprint Wealth’s DexCom DXCM Stock Holding History

Imprint Wealth’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-5
Closed -$336 – 330
2025
Q3 		$336 Buy
+5
New +$396 ﹤0.01% 320

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Imprint Wealth's DXCM Position: Q4 2025 in Review

Imprint Wealth sold out of DexCom (DXCM) in Q4 2025, closing a stake of 5 shares — an estimated $336 sold.

Imprint Wealth first reported a position in DXCM in Q3 2025 and held it in 1 quarter. The position peaked at $336 in Q3 2025. 922 funds tracked by Wall St. Rank hold DXCM as of Q4 2025.

  • Imprint Wealth reported no remaining DexCom position as of Q4 2025 after selling out during the quarter.
  • Imprint Wealth sold 5 DexCom shares in Q4 2025, an estimated $336.
  • Imprint Wealth first reported a position in DexCom in Q3 2025 and held it in 1 quarter.
  • Imprint Wealth's DexCom position peaked at $336 in Q3 2025.
  • 922 funds tracked by Wall St. Rank held DexCom as of Q4 2025.

Based on Imprint Wealth's 13F filing for Q4 2025, filed 17 Feb 2026.